You are here: Industry Insights > treatment-resistant

News List

FDA Approves Drug for Treatment-Resistant forms of TB americanpharmaceuticalreview
August 15, 2019
The U.S. Food and Drug Administration (FDA) approved Pretomanid Tablets in combination with bedaquiline and linezolid for the treatment of a specific type of highly treatment-resistant tuberculosis (TB) of the lungs.
Phase III success for Janssen’s esketamine in treatment-resistant depression pharmatimes
June 21, 2018
Janssen has presented data from pivotal Phase III clinical studies backing use of esketamine spray in treatment-resistant depression.
Attacking treatment-resistant prostate cancer by blocking its stress response fiercebiotech
May 03, 2018
Prostate cancer cells rely on protein synthesis to fuel their growth, but there can be too much of a good thing: Prostate tumors that are flooded with protein will actually die.
Amorsa to collaborate with J&J on treatment-resistant depression therapy europeanpharmaceuticalreview
January 06, 2017
Amorsa Therapeutics has announced a research, option and license agreement with Janssen Pharmaceuticals to develop and commercialise a novel small molecule drug candidate for treatment-resistant depression based on Amorsa’s proprietary ketamine analog tec